Evidence map›Paper›PMID 21051536›Full record

ArticleThe Journal of biological chemistry2011

Slowly produced microRNAs control protein levels.

Zakary L Whichard, Adilson E Motter, Peter J Stein, Seth J Corey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Zakary L WhichardDepartment of Pediatrics and Cell and Molecular Biology, Children's Memorial Hospital and the Robert H Lurie Comprehensive Cancer Center, Northwestern University School of Medicine, Chicago, Illinois 60611, USA.
Adilson E Motter
Peter J Stein
Seth J Corey
Northwestern University · USNorthwestern Memorial Hospital · USRobert H. Lurie Comprehensive Cancer Center of Northwestern University

Funding

TRANS-NETWORK PROJECTSU54CA143869 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI O'HALLORAN, THOMAS V · 2009 to 2013
$12.8M
Targeted Therapy of Lyn in Myelodysplastic SyndromeR01CA108922 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI COREY, SETH JOEL · 2006 to 2010
$1.3M
Scaffolding Proteins in Macrophage PhagocytosisR01HL080052 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI COREY, SETH JOEL · 2005 to 2008
$1.3M
NCI NIH HHS 1U54CA143869-01NCI NIH HHS R01 CA108922NCI NIH HHS R01CA108922NCI NIH HHS U54 CA143869NHLBI NIH HHS R01 HL080052NHLBI NIH HHS R01HL080052
6 · The paper itself

Abstract

Proteins are the primary agents of function in biological systems, and their levels are critical control elements, reflecting the interplay between transcription, translation, and protein degradation. Here, we consider the role of microRNAs (miRNAs) in the post-transcriptional regulation of protein synthesis. To determine their impact on protein concentration, we constructed a mechanistic model consisting of four state variables and nine kinetic parameters that account for transcript sequestration and degradation via miRNA-mRNA complex formation. Our dynamical model predicts that, even when present in low copy number, miRNAs can exert potent effects on protein concentration. Sensitivity analysis of the steady-state solution indicates that miRNA synthesis commonly acts to fine-tune protein concentrations. However, the same analysis shows that for a small subset of miRNA-mRNA pairs characterized by slowly produced miRNAs, the miRNA synthesis rate is the dominant control element. Our model equations provide a tool to evaluate the importance of particular miRNAs on their target proteins and promote the development of miRNA-based therapies that target proteins associated with cancer, inflammation, and metabolic disorders.

Indexed as

Models, BiologicalProtein BiosynthesisAnimalsHumansInflammationMetabolic DiseasesMicroRNAsNeoplasmsRNA, MessengerMicroRNAsRNA, Messenger

Identifiers

PMID21051536
PMCPMC3039369
OpenAlexW1990135953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.